Picture of Kalvista Pharmaceuticals logo

KALV — Kalvista Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Brief: Kalvista Initiates Konfident-Kid Trial For On-Demand Treatment

June 27 (Reuters) - Kalvista Pharmaceuticals Inc
 KALV.O :
    * KALVISTA INITIATES KONFIDENT-KID TRIAL FOR ON-DEMAND
TREATMENT
OF HEREDITARY ANGIOEDEMA ATTACKS WITH SEBETRALSTAT IN CHILDREN
AGED 2 TO 11

Source text for Eikon:  ID:nBwbNQvvta 
Further company coverage:  KALV.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kalvista Pharmaceuticals

See all news